ArticleMolecular biology reports2026
Investigation of transcription factor NFκB-mediated autophagy regulation mechanisms in non-small cell lung cancer.
Article in Molecular biology reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
backgroundAutophagy is a conserved intracellular degradation and recycling process in eukaryotic cells. Autophagy dysfunction is linked to several diseases, including cancer. Depending on cancer type and context, autophagy may act as a tumor suppressor or promote tumor progression. Various cellular pathways regulate autophagy, among which the NFκB signaling pathway plays a dual role, either promoting or inhibiting autophagy. Since many cancer therapies affect both autophagy and NFκB, understanding their interaction can help develop more effective combination treatments. However, the specific mechanisms by which NFκB regulates autophagy in Non-Small Cell Lung Cancer (NSCLC) remain unclear. In this study, we aimed to elucidate this regulatory relationship and identify key genes involved. METHODS AND
resultsWe established NSCLC cell groups with NFκB overexpression or suppression, and with or without autophagy induction. Autophagy levels were assessed via western blot. RNA-seq analysis was performed to identify differentially expressed genes among these groups, and candidate regulators were selected based on expression patterns and in silico analysis. Selected genes were validated with qRT-PCR. Our results show that NFκB positively regulates autophagy-related processes in NSCLC cells, as reflected by altered LC3B-II levels. Genes with expression which decreased upon NFκB suppression but increased with NFκB overexpression under autophagy-induced conditions were identified as candidate regulators. Among these, the putative NFκB-NLRP3 regulatory relationship appears to play a particularly important role in the upregulation of autophagy.
conclusionsThis study provides an NSCLC-specific transcriptional framework linking NFκB activity to autophagy- and inflammation-associated gene networks. By integrating expression profiling and in silico analyses, we identify candidate NFκB-responsive genes, including NLRP3, that may contribute to autophagy-related cellular responses in NSCLC.
Indexed as
Identifiers
41686310What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.